A549 cells infected with IAV Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IKZF1
|
ENSG00000185811.12 | IKAROS family zinc finger 1 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_51152702 | 5.77 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr19_+_48673949 | 3.68 |
ENST00000328759.7
|
C19orf68
|
chromosome 19 open reading frame 68 |
chr11_-_9482010 | 2.72 |
ENST00000596206.1
|
AC132192.1
|
LOC644656 protein; Uncharacterized protein |
chr11_+_393428 | 2.57 |
ENST00000533249.1
ENST00000527442.1 |
PKP3
|
plakophilin 3 |
chr22_+_43547937 | 2.54 |
ENST00000329563.4
|
TSPO
|
translocator protein (18kDa) |
chr4_-_1723040 | 2.52 |
ENST00000382936.3
ENST00000536901.1 ENST00000303277.2 |
TMEM129
|
transmembrane protein 129 |
chr12_-_25150373 | 2.44 |
ENST00000549828.1
|
C12orf77
|
chromosome 12 open reading frame 77 |
chr22_-_50970506 | 2.35 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr8_-_21966893 | 2.22 |
ENST00000522405.1
ENST00000522379.1 ENST00000309188.6 ENST00000521807.2 |
NUDT18
|
nudix (nucleoside diphosphate linked moiety X)-type motif 18 |
chr19_+_56652643 | 2.20 |
ENST00000586123.1
|
ZNF444
|
zinc finger protein 444 |
chr11_+_392587 | 2.17 |
ENST00000534401.1
|
PKP3
|
plakophilin 3 |
chr16_+_30709530 | 2.11 |
ENST00000411466.2
|
SRCAP
|
Snf2-related CREBBP activator protein |
chr5_-_180229791 | 2.10 |
ENST00000504671.1
ENST00000507384.1 |
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr22_+_43547520 | 2.00 |
ENST00000337554.3
ENST00000396265.3 ENST00000583777.1 |
TSPO
|
translocator protein (18kDa) |
chr5_-_133747551 | 1.99 |
ENST00000395009.3
|
CDKN2AIPNL
|
CDKN2A interacting protein N-terminal like |
chr11_+_64879317 | 1.92 |
ENST00000526809.1
ENST00000279263.7 ENST00000524986.1 ENST00000534371.1 ENST00000540748.1 ENST00000525385.1 ENST00000345348.5 ENST00000531321.1 ENST00000529414.1 ENST00000526085.1 ENST00000530750.1 |
TM7SF2
|
transmembrane 7 superfamily member 2 |
chr17_-_45918539 | 1.90 |
ENST00000584123.1
ENST00000578323.1 ENST00000407215.3 ENST00000290216.9 |
SCRN2
|
secernin 2 |
chr9_-_130700080 | 1.87 |
ENST00000373110.4
|
DPM2
|
dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit |
chr7_-_1067968 | 1.77 |
ENST00000412051.1
|
C7orf50
|
chromosome 7 open reading frame 50 |
chr19_+_50148087 | 1.76 |
ENST00000601038.1
ENST00000595242.1 |
SCAF1
|
SR-related CTD-associated factor 1 |
chr14_+_55590646 | 1.76 |
ENST00000553493.1
|
LGALS3
|
lectin, galactoside-binding, soluble, 3 |
chr19_-_51611623 | 1.76 |
ENST00000421832.2
|
CTU1
|
cytosolic thiouridylase subunit 1 |
chr19_-_46272462 | 1.76 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
chr19_-_47735918 | 1.75 |
ENST00000449228.1
ENST00000300880.7 ENST00000341983.4 |
BBC3
|
BCL2 binding component 3 |
chr11_+_2421718 | 1.72 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
chr16_-_67190152 | 1.71 |
ENST00000486556.1
|
TRADD
|
TNFRSF1A-associated via death domain |
chr17_-_18266818 | 1.70 |
ENST00000583780.1
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble) |
chr7_+_150756657 | 1.67 |
ENST00000413384.2
|
SLC4A2
|
solute carrier family 4 (anion exchanger), member 2 |
chr22_+_35776354 | 1.66 |
ENST00000412893.1
|
HMOX1
|
heme oxygenase (decycling) 1 |
chr10_-_73533255 | 1.65 |
ENST00000394957.3
|
C10orf54
|
chromosome 10 open reading frame 54 |
chr1_-_1310870 | 1.65 |
ENST00000338338.5
|
AURKAIP1
|
aurora kinase A interacting protein 1 |
chr4_+_76649753 | 1.63 |
ENST00000603759.1
|
USO1
|
USO1 vesicle transport factor |
chr8_+_22423479 | 1.62 |
ENST00000522721.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
chr14_+_24563262 | 1.62 |
ENST00000559250.1
ENST00000216780.4 ENST00000560736.1 ENST00000396973.4 ENST00000559837.1 |
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
chr16_-_88717482 | 1.59 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
chr19_-_1592828 | 1.59 |
ENST00000592012.1
|
MBD3
|
methyl-CpG binding domain protein 3 |
chr19_-_47291843 | 1.58 |
ENST00000542575.2
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5 |
chr16_+_3070313 | 1.58 |
ENST00000326577.4
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr9_+_140172200 | 1.57 |
ENST00000357503.2
|
TOR4A
|
torsin family 4, member A |
chr20_+_327413 | 1.57 |
ENST00000609179.1
|
NRSN2
|
neurensin 2 |
chr1_-_156217829 | 1.56 |
ENST00000356983.2
ENST00000335852.1 ENST00000340183.5 ENST00000540423.1 |
PAQR6
|
progestin and adipoQ receptor family member VI |
chr8_-_19615538 | 1.56 |
ENST00000517494.1
|
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
chr22_+_43547877 | 1.56 |
ENST00000428336.1
|
TSPO
|
translocator protein (18kDa) |
chr11_+_63742050 | 1.56 |
ENST00000314133.3
ENST00000535431.1 |
COX8A
AP000721.4
|
cytochrome c oxidase subunit VIIIA (ubiquitous) Uncharacterized protein |
chr7_+_99699280 | 1.55 |
ENST00000421755.1
|
AP4M1
|
adaptor-related protein complex 4, mu 1 subunit |
chr11_+_2923423 | 1.55 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
chr19_-_46234119 | 1.54 |
ENST00000317683.3
|
FBXO46
|
F-box protein 46 |
chr11_+_118754475 | 1.54 |
ENST00000292174.4
|
CXCR5
|
chemokine (C-X-C motif) receptor 5 |
chr17_-_8027402 | 1.54 |
ENST00000541682.2
ENST00000317814.4 ENST00000577735.1 |
HES7
|
hes family bHLH transcription factor 7 |
chr3_-_9811674 | 1.54 |
ENST00000411972.1
|
CAMK1
|
calcium/calmodulin-dependent protein kinase I |
chr20_+_62694834 | 1.53 |
ENST00000415602.1
|
TCEA2
|
transcription elongation factor A (SII), 2 |
chr19_-_50979981 | 1.53 |
ENST00000595790.1
ENST00000600100.1 |
FAM71E1
|
family with sequence similarity 71, member E1 |
chr6_-_32160622 | 1.53 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
chr19_+_14551066 | 1.51 |
ENST00000342216.4
|
PKN1
|
protein kinase N1 |
chr14_-_23299009 | 1.51 |
ENST00000488800.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr19_-_14168391 | 1.50 |
ENST00000589048.1
|
PALM3
|
paralemmin 3 |
chr19_+_37960466 | 1.50 |
ENST00000589725.1
|
ZNF570
|
zinc finger protein 570 |
chr7_-_105926058 | 1.50 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr17_-_43210580 | 1.48 |
ENST00000538093.1
ENST00000590644.1 |
PLCD3
|
phospholipase C, delta 3 |
chr6_+_31514622 | 1.48 |
ENST00000376146.4
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
chr7_+_140396465 | 1.48 |
ENST00000476279.1
ENST00000247866.4 ENST00000461457.1 ENST00000465506.1 ENST00000204307.5 ENST00000464566.1 |
NDUFB2
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa |
chr14_+_24563510 | 1.48 |
ENST00000545054.2
ENST00000561286.1 ENST00000558096.1 |
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
chr11_+_66624527 | 1.47 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr19_+_48281803 | 1.47 |
ENST00000601048.1
|
SEPW1
|
selenoprotein W, 1 |
chr8_+_144099914 | 1.46 |
ENST00000521699.1
ENST00000520531.1 ENST00000520466.1 ENST00000521003.1 ENST00000522528.1 ENST00000522971.1 ENST00000519611.1 ENST00000521182.1 ENST00000519546.1 ENST00000523847.1 ENST00000522024.1 |
LY6E
|
lymphocyte antigen 6 complex, locus E |
chr2_-_85625857 | 1.43 |
ENST00000453973.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
chr19_+_41699103 | 1.43 |
ENST00000597754.1
|
CYP2S1
|
cytochrome P450, family 2, subfamily S, polypeptide 1 |
chr16_+_616995 | 1.43 |
ENST00000293874.2
ENST00000409527.2 ENST00000424439.2 ENST00000540585.1 |
PIGQ
NHLRC4
|
phosphatidylinositol glycan anchor biosynthesis, class Q NHL repeat containing 4 |
chr19_+_48281842 | 1.43 |
ENST00000509570.2
|
SEPW1
|
selenoprotein W, 1 |
chr9_+_139553306 | 1.42 |
ENST00000371699.1
|
EGFL7
|
EGF-like-domain, multiple 7 |
chr17_-_40346477 | 1.42 |
ENST00000593209.1
ENST00000587427.1 ENST00000588352.1 ENST00000414034.3 ENST00000590249.1 |
GHDC
|
GH3 domain containing |
chr19_+_17530838 | 1.40 |
ENST00000528659.1
ENST00000392702.2 ENST00000529939.1 |
MVB12A
|
multivesicular body subunit 12A |
chrX_-_48755030 | 1.40 |
ENST00000490755.2
ENST00000465150.2 ENST00000495490.2 |
TIMM17B
|
translocase of inner mitochondrial membrane 17 homolog B (yeast) |
chr19_-_5680891 | 1.40 |
ENST00000309324.4
|
C19orf70
|
chromosome 19 open reading frame 70 |
chr17_+_73084038 | 1.39 |
ENST00000578376.1
ENST00000329783.4 |
SLC16A5
|
solute carrier family 16 (monocarboxylate transporter), member 5 |
chr19_-_36505098 | 1.39 |
ENST00000252984.7
ENST00000486389.1 ENST00000378875.3 ENST00000485128.1 |
ALKBH6
|
alkB, alkylation repair homolog 6 (E. coli) |
chr11_+_61583721 | 1.38 |
ENST00000257261.6
|
FADS2
|
fatty acid desaturase 2 |
chr17_-_42100474 | 1.38 |
ENST00000585950.1
ENST00000592127.1 ENST00000589334.1 |
TMEM101
|
transmembrane protein 101 |
chr16_+_30662085 | 1.38 |
ENST00000569864.1
|
PRR14
|
proline rich 14 |
chr19_-_50381606 | 1.37 |
ENST00000391830.1
|
AKT1S1
|
AKT1 substrate 1 (proline-rich) |
chr6_-_26027480 | 1.37 |
ENST00000377364.3
|
HIST1H4B
|
histone cluster 1, H4b |
chr17_+_37809333 | 1.36 |
ENST00000443521.1
|
STARD3
|
StAR-related lipid transfer (START) domain containing 3 |
chr16_-_29910853 | 1.36 |
ENST00000308713.5
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
chr7_+_99699179 | 1.35 |
ENST00000438383.1
ENST00000429084.1 ENST00000359593.4 ENST00000439416.1 |
AP4M1
|
adaptor-related protein complex 4, mu 1 subunit |
chr11_+_60691924 | 1.34 |
ENST00000544065.1
ENST00000453848.2 ENST00000005286.4 |
TMEM132A
|
transmembrane protein 132A |
chr5_+_102200948 | 1.34 |
ENST00000511477.1
ENST00000506006.1 ENST00000509832.1 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr10_-_75168071 | 1.32 |
ENST00000394847.3
|
ANXA7
|
annexin A7 |
chr2_+_233734994 | 1.32 |
ENST00000331342.2
|
C2orf82
|
chromosome 2 open reading frame 82 |
chr11_+_64863587 | 1.31 |
ENST00000530773.1
ENST00000279281.3 ENST00000529180.1 |
VPS51
|
vacuolar protein sorting 51 homolog (S. cerevisiae) |
chr1_-_1293904 | 1.31 |
ENST00000309212.6
ENST00000342753.4 ENST00000445648.2 |
MXRA8
|
matrix-remodelling associated 8 |
chr18_+_20715416 | 1.31 |
ENST00000580153.1
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1 |
chr1_+_155051379 | 1.31 |
ENST00000418360.2
|
EFNA3
|
ephrin-A3 |
chr3_-_47517302 | 1.31 |
ENST00000441517.2
ENST00000545718.1 |
SCAP
|
SREBF chaperone |
chr19_-_19314162 | 1.30 |
ENST00000420605.3
ENST00000544883.1 ENST00000538165.2 ENST00000331552.7 |
NR2C2AP
|
nuclear receptor 2C2-associated protein |
chr16_+_30937213 | 1.29 |
ENST00000427128.1
|
FBXL19
|
F-box and leucine-rich repeat protein 19 |
chr8_+_22446763 | 1.29 |
ENST00000450780.2
ENST00000430850.2 ENST00000447849.1 |
AC037459.4
|
Uncharacterized protein |
chr3_-_50360192 | 1.29 |
ENST00000442581.1
ENST00000447092.1 ENST00000357750.4 |
HYAL2
|
hyaluronoglucosaminidase 2 |
chr19_+_2249308 | 1.28 |
ENST00000592877.1
ENST00000221496.4 |
AMH
|
anti-Mullerian hormone |
chr19_+_56652686 | 1.28 |
ENST00000592949.1
|
ZNF444
|
zinc finger protein 444 |
chr12_+_113860042 | 1.28 |
ENST00000403593.4
|
SDSL
|
serine dehydratase-like |
chr8_+_145734433 | 1.27 |
ENST00000301327.4
|
MFSD3
|
major facilitator superfamily domain containing 3 |
chr16_+_83986827 | 1.27 |
ENST00000393306.1
ENST00000565123.1 |
OSGIN1
|
oxidative stress induced growth inhibitor 1 |
chr16_+_29832634 | 1.27 |
ENST00000565164.1
ENST00000570234.1 |
MVP
|
major vault protein |
chr1_-_2345236 | 1.27 |
ENST00000508384.1
|
PEX10
|
peroxisomal biogenesis factor 10 |
chr19_+_1041212 | 1.26 |
ENST00000433129.1
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr19_+_50094866 | 1.26 |
ENST00000418929.2
|
PRR12
|
proline rich 12 |
chr14_-_23446003 | 1.26 |
ENST00000553911.1
|
AJUBA
|
ajuba LIM protein |
chr2_-_220042825 | 1.26 |
ENST00000409789.1
|
CNPPD1
|
cyclin Pas1/PHO80 domain containing 1 |
chr17_-_76975925 | 1.26 |
ENST00000591274.1
ENST00000589906.1 ENST00000591778.1 ENST00000589775.2 ENST00000585407.1 ENST00000262776.3 |
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein |
chr17_+_48351785 | 1.25 |
ENST00000507382.1
|
TMEM92
|
transmembrane protein 92 |
chr19_+_17905919 | 1.25 |
ENST00000318683.6
ENST00000600777.1 ENST00000595387.1 |
B3GNT3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
chr1_+_156611900 | 1.25 |
ENST00000457777.2
ENST00000424639.1 |
BCAN
|
brevican |
chr6_-_32143828 | 1.25 |
ENST00000412465.2
ENST00000375107.3 |
AGPAT1
|
1-acylglycerol-3-phosphate O-acyltransferase 1 |
chr10_+_46994087 | 1.25 |
ENST00000374317.1
|
GPRIN2
|
G protein regulated inducer of neurite outgrowth 2 |
chr15_-_74494779 | 1.23 |
ENST00000571341.1
|
STRA6
|
stimulated by retinoic acid 6 |
chr11_+_2397418 | 1.23 |
ENST00000530648.1
|
CD81
|
CD81 molecule |
chr1_+_3689325 | 1.23 |
ENST00000444870.2
ENST00000452264.1 |
SMIM1
|
small integral membrane protein 1 (Vel blood group) |
chr5_-_139930713 | 1.23 |
ENST00000602657.1
|
SRA1
|
steroid receptor RNA activator 1 |
chr7_-_73184588 | 1.22 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
chr16_+_3070356 | 1.22 |
ENST00000341627.5
ENST00000575124.1 ENST00000575836.1 |
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr19_-_59084647 | 1.22 |
ENST00000594234.1
ENST00000596039.1 |
MZF1
|
myeloid zinc finger 1 |
chr19_+_56652556 | 1.21 |
ENST00000337080.3
|
ZNF444
|
zinc finger protein 444 |
chr4_+_926171 | 1.21 |
ENST00000507319.1
ENST00000264771.4 |
TMEM175
|
transmembrane protein 175 |
chr17_-_202579 | 1.20 |
ENST00000577079.1
ENST00000331302.7 ENST00000536489.2 |
RPH3AL
|
rabphilin 3A-like (without C2 domains) |
chr16_-_57514277 | 1.20 |
ENST00000562008.1
ENST00000567214.1 |
DOK4
|
docking protein 4 |
chr16_+_29911666 | 1.20 |
ENST00000563177.1
ENST00000483405.1 |
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
chr4_-_2935674 | 1.20 |
ENST00000514800.1
|
MFSD10
|
major facilitator superfamily domain containing 10 |
chr16_-_29934558 | 1.20 |
ENST00000568995.1
ENST00000566413.1 |
KCTD13
|
potassium channel tetramerization domain containing 13 |
chr19_+_33668509 | 1.20 |
ENST00000592484.1
|
LRP3
|
low density lipoprotein receptor-related protein 3 |
chr4_+_2043689 | 1.19 |
ENST00000382878.3
ENST00000409248.4 |
C4orf48
|
chromosome 4 open reading frame 48 |
chr17_+_72426891 | 1.19 |
ENST00000392627.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr8_-_19615435 | 1.17 |
ENST00000523262.1
|
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
chr19_-_1592652 | 1.17 |
ENST00000156825.1
ENST00000434436.3 |
MBD3
|
methyl-CpG binding domain protein 3 |
chr17_+_80193644 | 1.17 |
ENST00000582946.1
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3 |
chr2_-_74692473 | 1.17 |
ENST00000535045.1
ENST00000409065.1 ENST00000414701.1 ENST00000448666.1 ENST00000233616.4 ENST00000452063.2 |
MOGS
|
mannosyl-oligosaccharide glucosidase |
chrX_-_153707545 | 1.16 |
ENST00000357360.4
|
LAGE3
|
L antigen family, member 3 |
chr16_-_67970990 | 1.16 |
ENST00000358514.4
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
chr9_-_117160738 | 1.16 |
ENST00000448674.1
|
RP11-9M16.2
|
RP11-9M16.2 |
chr15_+_91416092 | 1.15 |
ENST00000559353.1
|
FURIN
|
furin (paired basic amino acid cleaving enzyme) |
chr17_-_7145475 | 1.15 |
ENST00000571129.1
ENST00000571253.1 ENST00000573928.1 |
GABARAP
|
GABA(A) receptor-associated protein |
chr7_+_140396756 | 1.15 |
ENST00000460088.1
ENST00000472695.1 |
NDUFB2
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa |
chr22_+_21336267 | 1.14 |
ENST00000215739.8
|
LZTR1
|
leucine-zipper-like transcription regulator 1 |
chr10_+_99344071 | 1.14 |
ENST00000370647.4
ENST00000370646.4 |
HOGA1
|
4-hydroxy-2-oxoglutarate aldolase 1 |
chr19_+_13228917 | 1.13 |
ENST00000586171.1
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing |
chr19_-_51014588 | 1.13 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
chr15_+_75640068 | 1.13 |
ENST00000565051.1
ENST00000564257.1 ENST00000567005.1 |
NEIL1
|
nei endonuclease VIII-like 1 (E. coli) |
chr16_-_57880439 | 1.13 |
ENST00000565684.1
|
KIFC3
|
kinesin family member C3 |
chr7_-_45151272 | 1.13 |
ENST00000461363.1
ENST00000495078.1 ENST00000494076.1 ENST00000478532.1 ENST00000258770.3 ENST00000361278.3 |
TBRG4
|
transforming growth factor beta regulator 4 |
chr19_+_34287174 | 1.13 |
ENST00000587559.1
ENST00000588637.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
chr8_-_144886321 | 1.12 |
ENST00000526832.1
|
SCRIB
|
scribbled planar cell polarity protein |
chr19_+_56111680 | 1.12 |
ENST00000301073.3
|
ZNF524
|
zinc finger protein 524 |
chr14_+_74035763 | 1.12 |
ENST00000238651.5
|
ACOT2
|
acyl-CoA thioesterase 2 |
chr19_+_507299 | 1.12 |
ENST00000359315.5
|
TPGS1
|
tubulin polyglutamylase complex subunit 1 |
chr7_-_139168402 | 1.11 |
ENST00000393039.2
|
KLRG2
|
killer cell lectin-like receptor subfamily G, member 2 |
chr11_+_57227981 | 1.11 |
ENST00000335099.3
|
RTN4RL2
|
reticulon 4 receptor-like 2 |
chr22_-_42343117 | 1.11 |
ENST00000407253.3
ENST00000215980.5 |
CENPM
|
centromere protein M |
chr11_+_64889773 | 1.11 |
ENST00000534078.1
ENST00000526171.1 ENST00000279242.2 ENST00000531705.1 ENST00000533943.1 |
MRPL49
|
mitochondrial ribosomal protein L49 |
chr19_-_17366257 | 1.11 |
ENST00000594059.1
|
AC010646.3
|
Uncharacterized protein |
chr8_+_22423168 | 1.11 |
ENST00000518912.1
ENST00000428103.1 |
SORBS3
|
sorbin and SH3 domain containing 3 |
chr11_+_844067 | 1.11 |
ENST00000397406.1
ENST00000409543.2 ENST00000525201.1 |
TSPAN4
|
tetraspanin 4 |
chr7_+_5322561 | 1.11 |
ENST00000396872.3
ENST00000444741.1 ENST00000297195.4 ENST00000406453.3 |
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4 |
chr19_+_46010674 | 1.10 |
ENST00000245932.6
ENST00000592139.1 ENST00000590603.1 |
VASP
|
vasodilator-stimulated phosphoprotein |
chr7_-_150777874 | 1.10 |
ENST00000540185.1
|
FASTK
|
Fas-activated serine/threonine kinase |
chr9_+_131445703 | 1.10 |
ENST00000454747.1
|
SET
|
SET nuclear oncogene |
chr6_-_30043539 | 1.10 |
ENST00000376751.3
ENST00000244360.6 |
RNF39
|
ring finger protein 39 |
chr19_+_56116771 | 1.10 |
ENST00000568956.1
|
ZNF865
|
zinc finger protein 865 |
chr17_+_7123207 | 1.10 |
ENST00000584103.1
ENST00000579886.2 |
ACADVL
|
acyl-CoA dehydrogenase, very long chain |
chr19_-_55895966 | 1.09 |
ENST00000444469.3
|
TMEM238
|
transmembrane protein 238 |
chr10_-_126849626 | 1.09 |
ENST00000530884.1
|
CTBP2
|
C-terminal binding protein 2 |
chr7_+_150725510 | 1.09 |
ENST00000461373.1
ENST00000358849.4 ENST00000297504.6 ENST00000542328.1 ENST00000498578.1 ENST00000356058.4 ENST00000477719.1 ENST00000477092.1 |
ABCB8
|
ATP-binding cassette, sub-family B (MDR/TAP), member 8 |
chr11_+_2923499 | 1.09 |
ENST00000449793.2
|
SLC22A18
|
solute carrier family 22, member 18 |
chr19_+_50879705 | 1.09 |
ENST00000598168.1
ENST00000411902.2 ENST00000253727.5 ENST00000597790.1 ENST00000597130.1 ENST00000599105.1 |
NR1H2
|
nuclear receptor subfamily 1, group H, member 2 |
chr2_-_45165994 | 1.09 |
ENST00000444871.2
|
RP11-89K21.1
|
RP11-89K21.1 |
chr19_-_41256207 | 1.09 |
ENST00000598485.2
ENST00000470681.1 ENST00000339153.3 ENST00000598729.1 |
C19orf54
|
chromosome 19 open reading frame 54 |
chr19_-_55791058 | 1.09 |
ENST00000587959.1
ENST00000585927.1 ENST00000587922.1 ENST00000585698.1 |
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
chr1_-_54518865 | 1.08 |
ENST00000371337.3
|
TMEM59
|
transmembrane protein 59 |
chr16_+_67313412 | 1.08 |
ENST00000379344.3
ENST00000568621.1 ENST00000450733.1 ENST00000567938.1 |
PLEKHG4
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 4 |
chr19_+_41092680 | 1.08 |
ENST00000594298.1
ENST00000597396.1 |
SHKBP1
|
SH3KBP1 binding protein 1 |
chr19_+_1041187 | 1.08 |
ENST00000531467.1
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr19_+_51153045 | 1.08 |
ENST00000458538.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr4_-_140223614 | 1.07 |
ENST00000394223.1
|
NDUFC1
|
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
chr6_+_30029008 | 1.07 |
ENST00000332435.5
ENST00000376782.2 ENST00000359374.4 ENST00000376785.2 |
ZNRD1
|
zinc ribbon domain containing 1 |
chr11_+_67195917 | 1.07 |
ENST00000524934.1
ENST00000539188.1 ENST00000312629.5 |
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2 |
chr17_+_2264983 | 1.07 |
ENST00000574650.1
|
SGSM2
|
small G protein signaling modulator 2 |
chr1_-_153950116 | 1.07 |
ENST00000368589.1
|
JTB
|
jumping translocation breakpoint |
chr12_-_7245018 | 1.06 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr2_-_74730430 | 1.06 |
ENST00000460508.3
|
LBX2
|
ladybird homeobox 2 |
chr5_-_140053152 | 1.06 |
ENST00000542735.1
|
DND1
|
DND microRNA-mediated repression inhibitor 1 |
chr16_-_2260834 | 1.06 |
ENST00000562360.1
ENST00000566018.1 |
BRICD5
|
BRICHOS domain containing 5 |
chr15_-_75135453 | 1.06 |
ENST00000569437.1
ENST00000440863.2 |
ULK3
|
unc-51 like kinase 3 |
chr1_+_180165672 | 1.06 |
ENST00000443059.1
|
QSOX1
|
quiescin Q6 sulfhydryl oxidase 1 |
chr7_+_6522922 | 1.06 |
ENST00000601673.1
|
FLJ20306
|
CDNA FLJ20306 fis, clone HEP06881; Putative uncharacterized protein FLJ20306; Uncharacterized protein |
chr19_-_10491130 | 1.05 |
ENST00000530829.1
ENST00000529370.1 |
TYK2
|
tyrosine kinase 2 |
chr11_+_2397402 | 1.05 |
ENST00000475945.2
|
CD81
|
CD81 molecule |
chr16_+_3014269 | 1.05 |
ENST00000575885.1
ENST00000571007.1 ENST00000319500.6 |
KREMEN2
|
kringle containing transmembrane protein 2 |
chr12_+_123459127 | 1.05 |
ENST00000397389.2
ENST00000538755.1 ENST00000536150.1 ENST00000545056.1 ENST00000545612.1 ENST00000538628.1 ENST00000545317.1 |
OGFOD2
|
2-oxoglutarate and iron-dependent oxygenase domain containing 2 |
chr17_+_72772621 | 1.05 |
ENST00000335464.5
ENST00000417024.2 ENST00000578764.1 ENST00000582773.1 ENST00000582330.1 |
TMEM104
|
transmembrane protein 104 |
chr5_-_180229833 | 1.05 |
ENST00000307826.4
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr19_+_36132631 | 1.04 |
ENST00000379026.2
ENST00000379023.4 ENST00000402764.2 ENST00000479824.1 |
ETV2
|
ets variant 2 |
chr17_-_41174424 | 1.04 |
ENST00000355653.3
|
VAT1
|
vesicle amine transport 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 6.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
1.0 | 3.9 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.9 | 0.9 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.9 | 2.8 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.8 | 2.3 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
0.7 | 2.2 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.6 | 2.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 5.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.6 | 2.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.6 | 1.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.6 | 5.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 1.7 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.5 | 3.3 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.5 | 0.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.5 | 1.1 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.5 | 2.1 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.5 | 1.6 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.5 | 1.6 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.5 | 2.1 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.5 | 2.6 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.5 | 2.0 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.5 | 2.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.5 | 2.0 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.5 | 1.5 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.5 | 2.4 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.5 | 2.4 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.5 | 3.4 | GO:0046618 | drug export(GO:0046618) |
0.5 | 1.4 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.5 | 1.4 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.5 | 1.4 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
0.5 | 2.3 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.4 | 2.7 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.4 | 1.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.4 | 4.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 2.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.4 | 0.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 2.8 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.4 | 1.6 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.4 | 1.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 2.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.4 | 1.2 | GO:0048627 | myoblast development(GO:0048627) |
0.4 | 1.6 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.4 | 1.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.4 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.4 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 7.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 2.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.4 | 3.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 1.1 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.4 | 1.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 1.4 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.4 | 0.4 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.3 | 2.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.3 | 1.4 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.3 | 2.7 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 1.0 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.3 | 2.0 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 1.0 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.3 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 2.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 1.3 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.3 | 1.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.3 | 1.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 0.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 0.9 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
0.3 | 3.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 0.9 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.3 | 0.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.3 | 2.5 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.3 | 1.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.9 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.3 | 1.2 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.3 | 1.2 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.3 | 2.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 3.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 3.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 1.2 | GO:0006565 | cysteine biosynthetic process from serine(GO:0006535) L-serine catabolic process(GO:0006565) |
0.3 | 1.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.3 | 2.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 0.9 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 0.9 | GO:0061433 | cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
0.3 | 1.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.3 | 0.6 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.3 | 0.8 | GO:1905204 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.3 | 1.7 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.3 | 0.8 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
0.3 | 2.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 1.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 0.5 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.3 | 1.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.3 | 1.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 0.8 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.3 | 0.8 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.3 | 2.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.3 | 0.3 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.3 | 0.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.3 | 1.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.3 | 1.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.3 | 1.0 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.3 | 1.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.5 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.3 | 0.8 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 1.8 | GO:0060356 | leucine import(GO:0060356) |
0.3 | 0.8 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.2 | 1.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.7 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.2 | 1.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 1.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 3.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 1.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.9 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.2 | 1.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.2 | 0.9 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.7 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.2 | 1.2 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.2 | 1.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.7 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.2 | 1.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.7 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.2 | 0.9 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.2 | 3.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.7 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 0.9 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.2 | 0.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.2 | 1.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 2.4 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.9 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.2 | 0.9 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.2 | 1.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.2 | 1.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 1.1 | GO:2000330 | positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.2 | 1.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.6 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.2 | 1.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.2 | 1.9 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.2 | 0.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.8 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 0.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 0.6 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.2 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.4 | GO:0051958 | methotrexate transport(GO:0051958) |
0.2 | 1.0 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.2 | 0.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 0.6 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.2 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 1.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 1.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.8 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.2 | 3.9 | GO:0045008 | depyrimidination(GO:0045008) |
0.2 | 0.6 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.2 | 0.6 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 1.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.2 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 1.2 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.2 | 1.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.8 | GO:0019046 | release from viral latency(GO:0019046) |
0.2 | 1.0 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.2 | 1.2 | GO:0018032 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.2 | 2.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.2 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 1.6 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.2 | 0.6 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.2 | 1.2 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.2 | 0.6 | GO:0032618 | interleukin-15 production(GO:0032618) |
0.2 | 0.4 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.2 | 0.2 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.6 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.2 | 0.2 | GO:2001076 | thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.2 | 1.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 1.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.2 | 1.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.2 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 0.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.2 | 0.6 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.2 | 1.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 5.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.5 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.2 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 1.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.2 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 2.7 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.2 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.9 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.2 | 0.5 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 0.7 | GO:0072237 | metanephric proximal tubule development(GO:0072237) metanephric distal tubule morphogenesis(GO:0072287) |
0.2 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.5 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.5 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.2 | 0.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.2 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.2 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.2 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.8 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 1.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.5 | GO:0015793 | glycerol transport(GO:0015793) |
0.2 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 1.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.7 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.7 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.2 | 2.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 0.2 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.2 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.2 | 0.8 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 0.5 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.2 | 0.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 0.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.6 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.2 | 3.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.2 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 2.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.9 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 1.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 1.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 2.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.2 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 1.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 1.9 | GO:0009304 | tRNA transcription(GO:0009304) |
0.2 | 0.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.2 | 1.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.3 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 0.2 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
0.2 | 0.5 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.2 | 1.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.2 | 1.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 0.5 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.2 | 0.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.2 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.2 | 0.5 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
0.1 | 0.9 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.1 | 1.5 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.4 | GO:0035623 | renal glucose absorption(GO:0035623) |
0.1 | 0.4 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.3 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.1 | 0.7 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.1 | 0.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 2.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.7 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 2.6 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.1 | GO:0061227 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.1 | 0.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 0.4 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.4 | GO:2000410 | activation of MAPK activity involved in innate immune response(GO:0035419) regulation of thymocyte migration(GO:2000410) |
0.1 | 0.4 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 2.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 2.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.3 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 1.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.1 | 0.8 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.9 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.3 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.1 | 0.4 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.1 | 0.4 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
0.1 | 1.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.1 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.1 | 1.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.4 | GO:1990910 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.1 | 0.4 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.1 | 1.7 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 2.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.5 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 3.5 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 1.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.5 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 3.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.1 | GO:0060066 | oviduct development(GO:0060066) |
0.1 | 0.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.4 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 1.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.4 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.1 | 0.3 | GO:0060197 | cloacal septation(GO:0060197) |
0.1 | 0.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.1 | 0.9 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.1 | 0.4 | GO:0044209 | AMP salvage(GO:0044209) |
0.1 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 1.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 3.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:0075528 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.1 | 0.5 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.1 | 0.1 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.1 | 0.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.9 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.4 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.7 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.6 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.1 | 1.8 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.4 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.1 | 0.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.5 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.1 | GO:0035272 | exocrine system development(GO:0035272) |
0.1 | 0.6 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 4.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.1 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.1 | 0.6 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
0.1 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.2 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.1 | 1.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 1.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.5 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.1 | 0.4 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 0.2 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.1 | 3.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.1 | 0.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.6 | GO:0045007 | base-excision repair, AP site formation(GO:0006285) depurination(GO:0045007) |
0.1 | 0.7 | GO:0051604 | protein maturation(GO:0051604) |
0.1 | 0.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 1.0 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.3 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.1 | 1.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.6 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.1 | 0.8 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.8 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 1.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.9 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.7 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 1.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.3 | GO:0035349 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.1 | 0.8 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.7 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 1.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 3.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 1.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.2 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.1 | 1.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 2.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.4 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 1.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 1.5 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.5 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.1 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 1.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 2.0 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 2.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 2.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 2.7 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 1.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.2 | GO:1903963 | icosanoid secretion(GO:0032309) arachidonic acid secretion(GO:0050482) icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) arachidonate transport(GO:1903963) |
0.1 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 1.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.3 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
0.1 | 2.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.6 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 0.8 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.3 | GO:0002368 | B cell cytokine production(GO:0002368) |
0.1 | 0.4 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 1.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.4 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.4 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 0.3 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.1 | 0.3 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.1 | 1.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.5 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 0.5 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.1 | 0.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.2 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.1 | 0.6 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.1 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.6 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 9.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.7 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.4 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.1 | 0.4 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.1 | 1.2 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.7 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 2.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.2 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.1 | 0.2 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 1.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 2.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 1.3 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 1.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.4 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.1 | 0.4 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.5 | GO:0046916 | cellular iron ion homeostasis(GO:0006879) cellular transition metal ion homeostasis(GO:0046916) |
0.1 | 0.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.7 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 0.6 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 1.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 2.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.1 | 0.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 2.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 1.2 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.1 | 1.9 | GO:0097502 | mannosylation(GO:0097502) |
0.1 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.3 | GO:0060214 | endocardium formation(GO:0060214) |
0.1 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.3 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.1 | 1.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 2.2 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.3 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.1 | 0.4 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 2.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 1.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.1 | 1.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 1.6 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.7 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 1.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.5 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.1 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 0.2 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.3 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.1 | 0.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.8 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 2.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 1.1 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.7 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.1 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.2 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 0.2 | GO:1905033 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.1 | 0.2 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 1.4 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 | 0.1 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.4 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 2.7 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.6 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 2.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.1 | 0.1 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.1 | 0.7 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.5 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.1 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.2 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.1 | 0.5 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 1.0 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 1.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.4 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 1.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.5 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.4 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.1 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0072177 | mesonephric duct development(GO:0072177) |
0.1 | 0.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.5 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.1 | 0.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.1 | GO:1901570 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.1 | 1.2 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.3 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.1 | 0.1 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.1 | 0.3 | GO:0052418 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.1 | 0.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.6 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.5 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 1.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 1.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.6 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.1 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
0.1 | 1.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 1.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 2.0 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.4 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.8 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.1 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.1 | GO:0048806 | genitalia development(GO:0048806) |
0.1 | 0.7 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 1.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.2 | GO:1903781 | positive regulation of actin filament-based movement(GO:1903116) positive regulation of cardiac conduction(GO:1903781) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
0.1 | 0.3 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.1 | 0.2 | GO:0015822 | ornithine transport(GO:0015822) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.2 | GO:0050905 | neuromuscular process(GO:0050905) |
0.1 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 5.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 1.0 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.2 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
0.1 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 0.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 3.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 1.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.1 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
0.1 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.1 | 0.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 2.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.2 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.2 | GO:0060896 | neural plate development(GO:0001840) neural plate axis specification(GO:0021997) neural plate pattern specification(GO:0060896) |
0.1 | 0.5 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 0.3 | GO:0002517 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) |
0.1 | 0.3 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 0.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.8 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.1 | 0.1 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.3 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.1 | 0.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 1.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.0 | 2.4 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.4 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.2 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.0 | 0.4 | GO:0044211 | CTP salvage(GO:0044211) |
0.0 | 1.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 0.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.1 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.0 | 1.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.4 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.0 | 1.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 1.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 0.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.0 | 0.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.0 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.1 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.2 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 1.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 1.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.9 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.0 | 0.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.4 | GO:0032888 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.0 | 2.4 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.1 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
0.0 | 0.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 1.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.5 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.0 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.2 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.0 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.2 | GO:0010816 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.3 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 2.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.6 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.4 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.2 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.0 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.2 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.0 | 4.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.0 | 1.0 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.3 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.0 | 0.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.0 | 0.1 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.5 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.0 | GO:0072091 | regulation of stem cell proliferation(GO:0072091) |
0.0 | 0.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.0 | 0.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.0 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.0 | 0.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.0 | 0.1 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.0 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 1.4 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 1.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.0 | 0.2 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.2 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.0 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.0 | 0.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.1 | GO:0018016 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.2 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.0 | 0.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.6 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.0 | 0.1 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.0 | 0.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.1 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.0 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.1 | GO:0071529 | cementum mineralization(GO:0071529) |
0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 1.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.1 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.0 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.0 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.0 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.0 | 0.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.2 | GO:1904152 | retrograde protein transport, ER to cytosol(GO:0030970) regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.0 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.2 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.0 | 0.3 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.1 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.1 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.0 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.0 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.0 | 1.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.0 | GO:0043092 | L-amino acid import(GO:0043092) |
0.0 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.0 | 0.7 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.2 | GO:0021902 | forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.1 | GO:1904879 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.3 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.0 | GO:1902309 | regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.0 | 0.1 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.0 | 0.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.0 | 0.2 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.0 | 0.1 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.0 | 0.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.1 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.0 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
0.0 | 0.0 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.3 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.0 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.0 | 0.3 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 0.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.2 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.4 | GO:0060173 | appendage development(GO:0048736) limb development(GO:0060173) |
0.0 | 0.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.2 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.6 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.0 | 0.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.1 | GO:0060350 | endochondral bone morphogenesis(GO:0060350) |
0.0 | 0.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.0 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.0 | GO:0072078 | renal tubule morphogenesis(GO:0061333) nephron tubule morphogenesis(GO:0072078) nephron epithelium morphogenesis(GO:0072088) |
0.0 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.1 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.0 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.5 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.0 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.1 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.1 | GO:2000466 | negative regulation of glycogen (starch) synthase activity(GO:2000466) regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.0 | 0.1 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.0 | 0.2 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.6 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.4 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.0 | 0.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.0 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.0 | 0.2 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.3 | GO:0042991 | transcription factor import into nucleus(GO:0042991) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.0 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 1.1 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.0 | 0.0 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) |
0.0 | 0.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 | 0.1 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.6 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.0 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.0 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.0 | 0.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.0 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.1 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA import into nucleus(GO:0061015) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.0 | 0.3 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.0 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0010962 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
0.0 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.0 | GO:0001678 | cellular glucose homeostasis(GO:0001678) |
0.0 | 0.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.0 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.5 | 2.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 2.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.4 | 3.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 2.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.3 | 2.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 3.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 1.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.3 | 0.9 | GO:0035101 | FACT complex(GO:0035101) |
0.3 | 1.5 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.3 | 3.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 1.1 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 0.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.3 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.3 | 4.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 1.9 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 2.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 1.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.3 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.3 | 1.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 2.9 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 0.8 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.3 | 2.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 2.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 1.9 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.9 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.2 | 3.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.6 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.2 | 0.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 0.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.6 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.2 | 4.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.2 | 0.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 3.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.6 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 0.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 3.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 3.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 2.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.2 | 0.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 1.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.2 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 1.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.3 | GO:0097361 | CIA complex(GO:0097361) |
0.2 | 1.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 0.6 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 2.9 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 1.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.1 | 0.7 | GO:0002133 | polycystin complex(GO:0002133) |
0.1 | 2.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 1.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.6 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.1 | 3.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.4 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.1 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.6 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 1.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 1.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 1.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 1.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.8 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 1.0 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.1 | 0.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.2 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
0.1 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.3 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.1 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 3.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.1 | 0.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.3 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 2.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 3.7 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.0 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 1.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 3.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 6.5 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 6.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.1 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.2 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 12.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 1.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 1.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.3 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.2 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 0.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 2.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 1.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.2 | GO:0000806 | Y chromosome(GO:0000806) cyclin E1-CDK2 complex(GO:0097134) |
0.1 | 1.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.1 | 0.3 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 0.8 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 1.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.9 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 4.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 2.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.0 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 1.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 2.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 3.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 4.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 1.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.4 | GO:0055028 | cortical microtubule(GO:0055028) |
0.0 | 0.0 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.0 | 0.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.0 | 0.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 1.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.0 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.0 | 0.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.0 | 0.1 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.0 | 0.6 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 1.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 2.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.0 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 21.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.0 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 2.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 1.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 2.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 1.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.2 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 4.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 2.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.0 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 167.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.5 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.0 | 0.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.0 | 0.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.0 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 0.2 | GO:0005816 | equatorial microtubule organizing center(GO:0000923) spindle pole body(GO:0005816) |
0.0 | 0.1 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 1.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.7 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.0 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.0 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
1.0 | 3.0 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.9 | 6.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.9 | 2.6 | GO:0004324 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.7 | 2.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.7 | 2.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 1.9 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.6 | 1.9 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.6 | 5.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.6 | 3.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.6 | 2.3 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.6 | 4.5 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.6 | 2.2 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.6 | 1.7 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.5 | 2.1 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.5 | 1.6 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.5 | 2.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.5 | 2.6 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.5 | 1.5 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.5 | 1.5 | GO:0070364 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.5 | 2.0 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.5 | 6.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.5 | 2.4 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.5 | 1.9 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.5 | 0.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 1.4 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.5 | 1.4 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.5 | 1.4 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.4 | 2.2 | GO:0070905 | serine binding(GO:0070905) |
0.4 | 1.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 2.5 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.4 | 4.2 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.4 | 1.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.4 | 1.6 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.4 | 1.6 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.4 | 0.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 1.6 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) leukotriene receptor activity(GO:0004974) |
0.4 | 1.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.4 | 2.7 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.4 | 1.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 1.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 1.1 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.3 | 8.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.0 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.3 | 1.0 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.3 | 1.6 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
0.3 | 1.6 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.3 | 1.9 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.3 | 1.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 0.9 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.3 | 1.5 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 0.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 0.9 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.3 | 2.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.3 | 1.8 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.3 | 1.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 1.5 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.3 | 1.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 1.2 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.3 | 2.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.2 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.3 | 0.9 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.3 | 1.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 0.9 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
0.3 | 0.8 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.3 | 0.8 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.3 | 1.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 3.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 0.8 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.3 | 0.8 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.3 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 0.8 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.3 | 1.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 0.8 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.3 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 1.8 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.3 | 0.8 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.3 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 1.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 2.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.5 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.2 | 1.4 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 0.7 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 0.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 0.9 | GO:0004335 | galactokinase activity(GO:0004335) |
0.2 | 0.9 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 1.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 2.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.2 | 0.9 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.9 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.2 | 1.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 0.7 | GO:0031780 | melanocortin receptor binding(GO:0031779) corticotropin hormone receptor binding(GO:0031780) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) type 5 melanocortin receptor binding(GO:0031783) type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 2.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.2 | 0.6 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.2 | 0.6 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.2 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 1.5 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.2 | 0.6 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.2 | 0.8 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.2 | 1.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 0.4 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.2 | 0.8 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.2 | 1.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.2 | 0.6 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.2 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 0.6 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.2 | 1.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 1.0 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.2 | 1.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 2.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 1.2 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.2 | 0.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.2 | 2.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 3.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.8 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.2 | 1.2 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 2.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.4 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.6 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.2 | 0.6 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 1.0 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.2 | 0.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.4 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 0.6 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.2 | 0.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.5 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.2 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.5 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.2 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.5 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 1.9 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.7 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.2 | 0.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 5.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.2 | 0.5 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.2 | 2.2 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.2 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.7 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.2 | 0.7 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.2 | 1.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.3 | GO:0070026 | nitric oxide binding(GO:0070026) |
0.2 | 3.1 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.2 | 4.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.8 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.6 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.2 | 0.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 1.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 1.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 1.2 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.2 | 0.2 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.4 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.1 | 0.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 1.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 1.9 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.9 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 1.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 1.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 2.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 3.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 5.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 1.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 1.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 3.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 1.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.8 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.8 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.1 | 0.5 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 1.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 2.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.4 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 1.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 1.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.8 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 1.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 3.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.5 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.1 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.4 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 0.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.4 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) ciliary neurotrophic factor binding(GO:0070119) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 2.0 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 1.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 1.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 0.5 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 1.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.3 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.1 | 0.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.3 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.1 | 0.3 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.1 | 1.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.3 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.7 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 1.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 1.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.4 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.1 | 1.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.5 | GO:0010736 | serum response element binding(GO:0010736) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 3.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.8 | GO:0000827 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 7.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 1.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 1.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.5 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.1 | 1.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.1 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.6 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.1 | 4.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 1.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.2 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.1 | 0.3 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.5 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.0 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.3 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.4 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 2.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.3 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 1.1 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 1.5 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 2.6 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 2.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.1 | 1.5 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 1.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.1 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 1.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.3 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.1 | 0.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.1 | 0.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.4 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 1.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 3.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 1.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.8 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 1.7 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 1.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.1 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 3.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 2.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 1.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.2 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.1 | 0.5 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 1.1 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.1 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.1 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.1 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.3 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 1.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 2.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
0.1 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.1 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.1 | 0.2 | GO:0047708 | biotinidase activity(GO:0047708) |
0.1 | 0.2 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.2 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.1 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.3 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.0 | 2.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 2.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 1.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.6 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.3 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.0 | 0.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.5 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.0 | 0.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.0 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
0.0 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.0 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 0.2 | GO:1903135 | cupric ion binding(GO:1903135) |
0.0 | 0.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 1.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.0 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.0 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.0 | 0.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 2.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.0 | 0.1 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.0 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.0 | 0.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.0 | 0.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.3 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0052827 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol pentakisphosphate phosphatase activity(GO:0052827) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.0 | 0.1 | GO:0050693 | DBD domain binding(GO:0050692) LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0008431 | vitamin E binding(GO:0008431) |
0.0 | 0.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.0 | 1.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.0 | 0.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.0 | 0.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 1.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.0 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.0 | 1.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 1.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 2.3 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 1.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 1.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.0 | 1.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.0 | 0.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.0 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.0 | 0.1 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 1.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.0 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.0 | 1.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.0 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 1.5 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.4 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.1 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 0.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.0 | 0.1 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.0 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 4.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 6.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 5.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 6.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 6.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 5.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 7.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 4.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 7.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 3.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 1.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 2.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 3.9 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 6.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 4.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 4.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 2.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 5.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 3.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 6.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 7.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 7.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 3.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 2.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 7.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 3.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 3.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 7.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 6.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 5.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 5.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 4.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 2.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 2.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 4.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 1.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 3.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.2 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 3.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 2.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.6 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 3.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 2.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.0 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 1.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 1.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 1.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 1.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |